Mechanisms of hormone-mediated carcinogenesis of the ovary in mice.
Experimental ovarian carcinogenesis has been investigated in inbred and hybrid strains of mice and induced by a diversity of mechanisms including X-irradiation, oocytotoxic xenobiotic chemicals, ovarian grafting to ectopic or orthotopic sites, neonatal thymectomy, mutant genes reducing germ cell populations, and aging. The mechanisms are briefly reviewed whereby disruptions in the function of graafian follicles results in a spectrum of ovarian proliferative lesions including tumors. The findings in mutant mice support the concept of a secondary (hormonally-mediated) mechanism of ovarian carcinogenesis in mice associated with sterility. Multiple pathogenetic factors that either destroy or diminish the numbers of graafian follicles in the ovary result in decreased sex hormone secretion (especially estradiol-17 beta) leading to a compensatory over-production of pituitary gonadotrophins (particularly luteinizing hormone), which places the mouse ovary at an increased risk to develop tumors. The intense proliferation of ovarian surface epithelium and stromal (interstitial) cells with the development of unique tubular adenomas in response to sterility does not appear to have a counterpart in the ovaries of women.
Jackson Laboratory, Bar Harbor, ME 04609, USA.
C C
CC
Capen
W G
WG
Beamer
B J
BJ
Tennent
K A
KA
Stitzel
D000818:Animals; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology; D006728:Hormones / Q000502:physiology*; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D051379:Mice; D008817:Mice, Mutant Strains; D009582:Nitrofurantoin / Q000633:toxicity; D010051:Ovarian Neoplasms / Q000209:etiology*
D006728:Hormones; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D009582:Nitrofurantoin